Quantcast

Latest Clinical trial Stories

2014-09-10 12:29:18

LONDON, ON, Sept. 10, 2014 /CNW/ - "Clinical testing has been one of the biggest barriers to developing new imaging technology for clinical application", says Alvira Macanovic, IP, Regulatory and Clinical Affairs Manager at the Centre for Imaging Technology Commercialization (CIMTEC). "This very important CIMTEC initiative will make it easier for researchers and small and medium-sized companies to achieve a range of goals such as generating clinical data to support pre-market...

2014-09-10 12:28:22

WASHINGTON, Sept. 10, 2014 /PRNewswire-USNewswire/ -- The following is a statement on behalf of RetireSafe: Dear Member of Congress; We write to you today to bring to your attention a critical safety issue that could affect all Americans, but especially those older Americans who rely on relatively new medicines called "biologics". RetireSafe, a 400,000-supporter strong nationwide advocacy organization for seniors, works hard to give a voice to retired Americans and those who hope to retire....

2014-09-10 08:30:43

New addition expands WCG's New England presence and increases its expertise in all phases of clinical research PRINCETON, N.J., Sept. 10, 2014 /PRNewswire/ -- WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced today that New England Independent Review Board (IRB) has joined the group of companies. Based near Boston, MA, New England IRB expands WCG's presence in the important New England clinical...

2014-09-09 23:09:41

Quorum Review IRB, the industry leader in central IRB services, announces a new streamlined service for Retrospective Chart Reviews. Seattle, WA (PRWEB) September 09, 2014 Quorum Review IRB, the industry leader in central IRB services, announces a new streamlined service for Retrospective Chart Reviews. The service was piloted earlier this year with several clients and was rolled out to all Quorum’s clients with the new Expeditable Research Review offering. The Retrospective Chart...

2014-09-09 23:02:43

Advanced new studies seek to uncover therapeutic interventions for FSHD Lexington, MASS (PRWEB) September 09, 2014 The FSH Society, a Massachusetts based non-profit that is a world leader in combating facioscapulohumeral dystrophy (FSHD), announced that it has awarded three grants totaling $193,150 to new research projects. Through these studies, the FSH Society’s fellowship and grant program aims to gain insights and achieve significant milestones into the research of FSHD, one of the...

2014-09-09 16:26:44

PLEASANTON, Calif., Sept. 9, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today that it has begun to enroll patients in the HeartMate III(TM) U.S. clinical trial. "We are excited to continue our recent pipeline progress with the start of the U.S. clinical trial for HeartMate III," said Gary F. Burbach, President and Chief Executive Officer....

2014-09-09 12:28:20

HealthiVibe bridges the gap between clinical trials and patient involvement. The company will present at Disruptive Innovations, September 10 & 12 in Boston. ARLINGTON, Va., Sept. 9, 2014 /PRNewswire/ -- HealthiVibe, LLC, a newly formed company, aims to pioneer a new model in which the patient voice becomes central to clinical trial development. Founded by Abbe Steel, a 23-year veteran of the pharmaceutical industry, HealthiVibe uses a novel approach to gathering patient feedback....

2014-09-09 12:28:04

- Only 28% of Parkinson's patients are currently receiving care from a Parkinson's specialist NEW YORK, Sept. 9, 2014 /PRNewswire-USNewswire/ -- A recent survey of more than 1,500 Parkinson's disease (PD) patients, caregivers and physicians reveals that information and specialized care can help patients become more engaged in their own treatment and in the Parkinson's community. http://photos.prnewswire.com/prnvar/20140909/144393 "When patients get to the right doctor, it...

2014-09-09 12:26:46

Clinical Trials Will Continue to Play a Key Role in this Growing Market, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept. 9, 2014 /PRNewswire/ -- Decision Resources Group finds that the United States interventional oncology device market will see strong growth, reaching a value of $760 million by 2023. Rising cancer incidence rates combined with the ineffectiveness of chemotherapy and demand for less invasive procedures will support interventional oncology device...

2014-09-09 08:31:51

ANTWERP, Belgium and DUBAI, UAE, September 9, 2014 /PRNewswire/ -- genae, a global Contract Research Organization (CRO) and services provider for the medical industries, announced today the incorporation of genae Gulf in Dubai, and the joint effort with leading clinicians from the region, including cardiologist Dr. Ibrahim Al Rashdan. "There is an exponentially growing demand for combining efforts between the Gulf region and the West, in terms of high quality but...


Word of the Day
virgule
  • A punctuation mark (/) used to separate related items of information.
  • A little rod; a twig.
This word comes from the Late Latin 'virgula,' accentual mark, a diminutive of 'virga,' rod.
Related